UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
about
A population-based gene signature is predictive of breast cancer survival and chemoresponseIndividualized survival and treatment response predictions in breast cancer patients: involvements of phospho-EGFR and phospho-Her2/neu proteinsAfrican ancestry and higher prevalence of triple-negative breast cancer: findings from an international studyQuantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosisThe changing global patterns of female breast cancer incidence and mortalityEffects of chronic widespread pain on the health status and quality of life of women after breast cancer surgeryModels of breast cancer: is merging human and animal models the future?Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study.Main controversies in breast cancerAdjuvant therapy for breast cancer: who should get what?Perceived benefits and psychosocial outcomes of a brief existential family intervention for cancer patients/survivors.Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression.Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening.MUC1-positive circulating tumor cells and MUC1 protein predict chemotherapeutic efficacy in the treatment of metastatic breast cancer.Treatment and survival in breast cancer in the Eastern Region of EnglandLack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyCancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer.The Long and Short of Tamoxifen Therapy: A Review of the ATLAS TrialDepression and anxiety in women with early breast cancer: five year observational cohort study.Challenges to the early diagnosis and treatment of breast cancer in developing countries.Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.Evaluation of breast cancer awareness among female university students in MalaysiaRegional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women.Women's participation in breast cancer screening in France--an ethical approachThe first national public breast cancer screening program in Saudi Arabia.Monitoring the progression of metastatic breast cancer on nanoporous silica chips.Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancerOptions for early breast cancer follow-up in primary and secondary care - a systematic review.Proteomic serum biomarkers and their potential application in cancer screening programs.Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.Phytohemagglutinin-induced mitotic index in blood lymphocytes: a potential biomarker for breast cancer risk.Mammography: a review of records in the Department of Radiology at a National Referral Hospital in UgandaDoses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy.A vision for the future?Recent trends in breast cancer incidence and mortality.Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women.The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence.
P2860
Q23909226-963E39FC-95E8-4753-870C-93D4FB45BAF4Q23916643-3B43EB0A-A3FB-49FF-B849-13929AC60780Q24632274-E4380EF6-1203-4747-BE1D-5A4AECD275FCQ24646799-013A4D4C-F8A2-42F1-8BFE-604D885CBB24Q24795947-51D9AC42-24CC-4C17-A222-7B31BE8F5D68Q24802191-65E3BB79-3768-41CD-82FD-0F3795C38739Q24803657-C057918D-4CF2-4C1F-88F4-6DECCC14FD6CQ25256941-0F92DD44-5FA7-4167-B223-0C29183131E4Q27026673-38371927-CE8A-4AB9-B3A1-40F7680183BEQ28362093-53CEC23E-7D15-4FB9-8310-44306A716184Q30401886-9E826713-55CE-43CB-99A8-23A740073B5AQ31158272-8F57E82C-2748-4122-BBAB-1853EC8AC067Q33532804-09CE8D92-9B40-4935-B556-B97B6EA6A359Q33574926-C0B9C2B2-EC1B-4EE6-ACCC-CDD9FB15BBC9Q33618132-BD9DF1D7-1ABA-4043-86E0-73A7DD55FCF2Q33630784-F661A849-25A5-411E-835E-7CD21922E236Q33642104-241BBA6E-D626-4750-9128-233A93EAFD76Q33768732-9FB6F7B9-3F1B-4EF1-AC41-372CFA576E68Q33779753-4E4868CA-102E-42F3-B2CB-324912EC3AF4Q33781804-37BCB00B-3227-40CC-8A31-0FCD44539384Q33886176-A5098195-747E-4204-95F1-D5E669C4A15EQ33934898-A0345B8B-3285-4AD4-9FA4-0E165566E458Q34023713-518A94B0-706F-42DC-9F86-5FA6CC5464F5Q34059713-5EC7E944-AE67-4F74-94C8-0AA8B40E7BCEQ34074871-9E4D00C9-B974-4933-9676-583F7635A203Q34100220-DB111DCC-8AC7-4215-B06B-01F7D0584374Q34116973-53FB9F3F-72A2-4D20-B000-15517F26CB0CQ34136084-1E5EE356-417C-466A-BED6-9C224BE4CB81Q34234831-92B07515-4087-4B7D-B56F-8E696003A4EEQ34284302-6CBE12D9-8ED0-4D5B-A2A7-493A7E44D415Q34303226-DBAA8F51-44AE-4A94-8A8B-2788C3442FBBQ34395996-47116E08-6E5B-437C-A192-FA0322E17509Q34423099-25C70A3D-8EC7-46A9-B90B-46CA0A418090Q34480468-76135909-612E-4466-B9B7-D3034C633819Q34507710-29F5FB90-1F67-4094-9E9E-6ACC600D5DF8Q34521998-9A6A0B9E-1FEF-4386-AB81-433579169FD0Q34568113-191BD3A0-6D40-4CDB-86E4-0A3159B8109EQ34580662-26648F90-9770-4399-A4B2-AA68DF0C832BQ34626963-8B82FCFD-89AE-4C19-BC41-3375FEE73B0EQ34744234-9639B239-6483-4FE3-8A48-01DDAAC98B2F
P2860
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
@en
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
@nl
type
label
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
@en
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
@nl
prefLabel
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
@en
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
@nl
P2093
P1433
P1476
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
@en
P2093
P356
10.1016/S0140-6736(00)02277-7
P407
P577
2000-05-01T00:00:00Z